Sunday, November 17, 2024

TOPIC

bharat biotech

COVID-19 vaccination: Serum Institute receives purchase order for 11 million doses from Govt of India

Covishield vaccine produced by the Seru Institute of India to be available at Rs 200 per dose.

‘Cause of death is poisoning, not vaccine’: Bharat Biotech issues clarification after phase 3 trial participant for Covaxin dies in Bhopal

The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin

COVID-19 vaccination in India to start from 16 January, 30 crore including frontline workers, aged and high-risk people to be vaccinated

The vaccination will start after the forthcoming festivals across the country including Lohri, Makar Sankranti, Pongal, Magh Bihu etc

Massive: Improved coronavirus recovery puts India out of top ten countries with most active COVID cases

For a country this size with the massive population as well as innumerable hurdles, India has indeed done a tremendous job in containing coronavirus pandemic.

Serum Institute and Bharat Biotech pledge smooth rollout of COVID-19 vaccines in a joint statement, lay controversy to rest: Details

The Indian regulatory body has approved emergency use of both Serum Institute developed Covishield and Bharat Biotech's Covaxin to combat the coronavirus

Dr Gagandeep Kang who cast aspersions on indigenously made COVID-19 vaccines is an anti-Modi Dhruv Rathee fan: Details

Dr Gangandeep Kang was one of the 150 'scientists' who signed a letter indirectly asking the voters to vote against PM Modi in 2019.

COVID vaccines: A comprehensive list of FAQs to clear doubts about the vaccines and immunisation drive

The government has released a list of FAQs to clear doubts and dispel rumours regarding the the COVID vaccines.

Anil Vij tests positive for Coronavirus days after he joined third phase of vaccine trials: Here is why there is no reason to panic

As Covaxin trial is double blinded, there is 50% chance that Anil Vij got placebo in place of vaccine, and he only received one dose

India’s first Chinese coronavirus vaccine, COVAXIN, undergoes human trials: Here are the details

Human trials of indigenously prepared covid-19 vaccine COVAXIN starts across 12 trial centres in India

Bharat Biotech-ICMR to launch indigenous coronavirus vaccine COVAXIN by August 15

Hyderabad-based Bharat Biotech successfully developed Coronavirus vaccine COVAXIN™ in collaboration with the ICMR and NIV

Latest News

Recently Popular